Developing expertise, customising sleep, enhancing study practices: exploring the legitimisation of modafinil use within the accounts of UK undergraduate students

References

• Bancroft, A., & Reid, P.S. (2016). Concepts of illicit drug quality among darknet market users: Purity, embodied experience, craft and chemical knowledge. International Journal of Drug Policy, 35, 42–49. doi:10.1016/j.drugpo.2015.11.008
   PubMed Web of Science ®Google Scholar
• Bryman, A. (2008). Social research methods. 3rd ed. Oxford, New York: Oxford University Press.
   Google Scholar
• Cloatre, E., & Pickersgill, M. (2014). International law, public health, and the meanings of pharmaceuticalization. New Genetics and Society, 33, 434–449. doi:10.1080/14636778.2014.951994
   PubMed Web of Science ®Google Scholar
• Collin, J. (2016). On social plasticity: The transformative power of pharmaceuticals on health, nature and identity. Sociology of Health and Illness, 38, 73–89. doi:10.1111/1467-9566.12342
   PubMed Web of Science ®Google Scholar
• Coveney, C. (2011). Cognitive enhancement? Exploring modafinil use in social context. In: Pickersgill, M. & Van Keulen, I. (Eds.), Sociological reflections on the neurosciences, (pp. 203–229). Bingley: Emerald.
   Google Scholar
• Coveney, C. (2014). Managing sleep and wakefulness in a 24-hour world. Sociology of Health and Illness, 36, 123–136. doi:10.1111/1467-9566.12046
   PubMed Web of Science ®Google Scholar
• Coveney, C., Nerlich, B., & Martin, P. (2009). Modafinil in the media: Metaphors, medicalisation and the body. Social Science and Medicine, 68, 487–495. doi:10.1016/j.socscimed.2008.11.016
   PubMed Web of Science ®Google Scholar
• Coveney, C., Gabe, J., & Williams, S. (2011). The sociology of cognitive enhancement: Medicalisation and beyond. Health Sociology Review, 20, 381–393. doi:10.5172/hesr.2011.20.4.381
   Web of Science ®Google Scholar
• Cutler, K. (2014). Prescription stimulants are “a okay”: Applying neutralisation theory to college students’ nonmedical prescription stimulant use. Journal of American College Health, 62, 478–486. doi:10.1080/07448481.2014.929578
   PubMed Web of Science ®Google Scholar
• DeSantis, A., & Hane, A. (2010). “Adderall is definitely not a drug”: justifications for the illegal use of ADHD stimulants. Substance Use and Misuse, 45, 31–46. doi:10.3109/10826080902858334
   PubMed Web of Science ®Google Scholar
• DeSantis, A., Noar, S., & Webb, E. (2010). Speeding through the frat house: A qualitative exploration of nonmedical ADHD stimulant use in fraternities. Journal of Drug Education, 40, 157–171. doi:10.2190/DE.40.2.d
   PubMed Web of Science ®Google Scholar
• DeSantis, A., Webb, E., & Noar, S. (2008). Illicit use of prescription ADHD medications on a college campus: A multimethodological approach. Journal of American College Health, 57, 315–324. doi:10.3200/JACH.57.3.315-324
   PubMed Web of Science ®Google Scholar
• DeSouza, R. (2015). I’ve thought about this, trust me”: Understanding the values and assumptions underlying prescription stimulant misuse among college students. International Journal of Communication, 9, 1187–1205. doi:1932-8036/20150005
   Web of Science ®Google Scholar
• DuPont, R., Coleman, J., Bucher, R., & Wilford, B. (2008). Characteristics and motives of college students who engage in nonmedical use of methylphenidate. The American Journal on Addictions, 17, 167–171. doi:10.1080/10550490802019642
   PubMed Web of Science ®Google Scholar
• Eickenhorst, P., Vitzthum, K., Klapp, B., Groneberg, D., & Mache, S. (2012). Neuroenhancement among German university students: Motives, expectations, and relationships with psychoactive lifestyle drugs. Journal of Psychoactive Drugs, 44, 418–427. doi:10.1080/02791072.2012.736845
   PubMed Web of Science ®Google Scholar
• Elliott, C. (2011). Enhancement technologies and the modern self. Journal of Medicine and Philosophy, 36, 364–374. doi:10.1093/jmp/jhr031
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. (2010). Questions and Answers on the Review of Medicines Containing Modafinil. EMA/725532/2010 Rev.
   Google Scholar
• Forlini, C., & Racine, E. (2009a). Disagreements with implications: Diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. BMC Medical Ethics, 10, 9. Accessed on 4 January 2019. https://doi.org/10.1186/1472-6939-10-9
   PubMed Web of Science ®Google Scholar
• Forlini, C., & Racine, E. (2009b). Autonomy and coercion in academic “cognitive enhancement” using methylphenidate: Perspectives of key stakeholders. Neuroethics, 2, 163–177. doi:10.1007/s12152-009-9043-y
   Web of Science ®Google Scholar
• Forlini, C., Schildmann, J., Roser, P., Beranek, R., & Vollmann, J. (2015). Knowledge, experiences and views of German university students toward neuroenhancement: an empirical-ethical analysis. Neuroethics, 8, 83–92. doi:10.1007/s12152-014-9218-z
   Web of Science ®Google Scholar
• Gabe, J., & Bury, M. (1996). Risking tranquillizer use: Cultural and lay dimensions. In: Williams S. J. & Calnan M. (Eds.), Modern medicine: Lay perspectives and experiences. Abingdon: Routledge. pp 74–94.
   Google Scholar
• Gabe, J., Coveney, C.M., & Williams, S.J. (2016). Prescriptions and proscriptions: Moralising sleep medicines. Sociology of Health and Illness, 38, 627–644. doi:10.1111/1467-9566.12383
   PubMed Web of Science ®Google Scholar
• Hall, M., Grogan, S., & Gough, B. (2016). Bodybuilders accounts of synthol use: The construction of lay expertise. In: Hall, M., Grogan, S., & Gough, B. (Eds.), Chemically modified bodies (pp. 127–145). London: Palgrave Macmillan.
   Google Scholar
• HM Government. (2017). Drug penalties. URL: https://www.gov.uk/penalties-drug-possession-dealing [Date accessed: 06.03.17]
   Google Scholar
• Hildt, E., Lieb, K., & Franke, G. (2014). Life context of pharmacological academic performance enhancement among university students: A qualitative approach. BMC Medical Ethics, 15, 1–10. doi:10.1186/1472-6939-15-23
   PubMed Web of Science ®Google Scholar
• Hogle, L. (2005). Enhancement technologies and the body. Annual Review of Anthropology, 34, 695–716. doi:10.1146/annurev.anthro.33.070203.144020
   Web of Science ®Google Scholar
• Hupli, A., Didžiokaitė, G., & Ydema, M. (2016). Towards the smarter use of smart drugs: Perceptions and experiences of university students in the Netherlands and Lithuania. Contemporary Drug Problems, 43, 242–257. doi:10.1177/0091450916660143
   Google Scholar
• Ilieva, I.P., Hook, C.J., & Farah, M.J. (2015). Prescription stimulants effects on healthy inhibitory control, working memory, and episodic memory: A meta-analysis. Journal of Cognitive Neuroscience, 27, 1069–1089. doi:10.1162/jocn_a_00776
   PubMed Web of Science ®Google Scholar
• Jensen, C., Forlini, C., Partridge, B., & Hall, W. (2016). Australian university students' coping strategies and use of pharmaceutical stimulants as cognitive enhancers. Frontiers in Psychology, 7, 277. doi:10.3389/fpsyg.2016.00277
   PubMed Web of Science ®Google Scholar
• Judson, R., & Langdon, S. (2009). Illicit use of prescription stimulants among college students: Prescription status, motives, theory of planned behaviour, knowledge and self-diagnostic tendencies. Psychology, Health and Medicine, 14, 97–104. doi:10.1080/13548500802126723
   PubMed Web of Science ®Google Scholar
• Ketchum, F. (2013). Rethinking “cognitive” enhancement: The ethical stakes of user perspectives. AJOB Neuroscience, 4, 26–27. doi:10.1080/21507740.2012.748705
   Google Scholar
• Kolar, K. (2015). Study drugs “don’t make you smarter”: Acceptability evaluations of nonmedical prescription stimulant use among undergraduate students. Contemporary Drug Problems, 42, 314–330. doi:10.1177/0091450915614050
   Google Scholar
• Looby, A., Kassman, K., & Earleywine, M. (2014). Do negative stimulant-related attitudes vary for prescription stimulants and cocaine among college students?. Addictive Behaviors, 39, 1100–1105. doi:10.1016/j.addbeh.2014.03.012
   PubMed Web of Science ®Google Scholar
• Martin, E. (2006). The pharmaceutical person. BioSocieties, 1, 273–287. doi:10.1017/S1745855206003012
   Google Scholar
• McCabe, S., Knight, R., Teter, C., & Wechsler, H. (2005). Nonmedical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Journal of Addiction, 99, 96–106. doi:10.1111/j.1360-0443.2005.00944.x
   Web of Science ®Google Scholar
• Morrison, M. (2015). STS and enhancement technologies: A programme for future research. Science and Technology Studies, 28, 3–28.
   Web of Science ®Google Scholar
• Partridge, B., Bell, S., Lucke, J., & Hall, W. (2013). Australian university students’ attitudes towards the use of prescription stimulants as cognitive enhancers: Perceived patterns of use, efficacy and safety: Attitudes towards cognitive enhancement. Drug and Alcohol Review, 32, 295–302. doi:10.1111/dar.12005
   PubMed Web of Science ®Google Scholar
• Penn, R.A. (2014). Establishing expertise: Canadian community-based medical cannabis dispensaries as embodied health movement organisations. International Journal of Drug Policy, 25, 372–377. doi:10.1016/j.drugpo.2013.12.003
   PubMed Web of Science ®Google Scholar
• Petersen, M., Norgaard, L., & Traulsen, J. (2015). Pursuing pleasures of productivity: University students' use of prescription stimulants for enhancement and the moral uncertainty of making work fun. Culture, Medicine and Psychiatry, 39, 665–679. doi:10.1007/s11013-015-9457-4
   PubMed Web of Science ®Google Scholar
• Pickersgill, M., & Hogle, L. (2015). Enhancement, ethics and society: Towards an empirical research agenda for the medical humanities and social sciences. Medical Humanities, 41, 136–142. doi:10.1136/medhum-2015-010718
   PubMed Web of Science ®Google Scholar
• Racine, E., Rubio, T., M., Chandler, J., Forlini, C., & Lucke, J. (2014). The value and pitfalls of speculation about science and technology in bioethics: The case of cognitive enhancement. Medicine, Health Care and Philosophy, 17, 325–337. doi:10.1007/s11019-013-9539-4
   PubMed Web of Science ®Google Scholar
• Ragan, I., Bard, I., & Singh, I., Independent Scientific Committee on Drugs (2013). What should we do about student use of cognitive enhancers? An analysis of current evidence. Neuropharmacology, 64, 588–595. doi:10.1016/j.neuropharm.2012.06.016
   PubMed Web of Science ®Google Scholar
• Robitaille, C., & Collin, J. (2016). Prescription psychostimulant use among young adults: A narrative review of qualitative studies. Substance Use and Misuse, 51, 357–369. doi:10.3109/10826084.2015.1110170
   PubMed Web of Science ®Google Scholar
• Rönkä, S., & Katainen, A. (2017). Non-medical use of prescription drugs among illicit drug users: A case study on an online drug forum. International Journal of Drug Policy, 39, 62–68. doi:10.1016/j.drugpo.2016.08.013
   PubMed Web of Science ®Google Scholar
• Shook, J., Galvagni, L., & Giordano, J. (2014). Cognitive enhancement kept within contexts: Neuroethics and informed policy. Frontiers in Systems Neuroscience, 8, 1–8. doi:10.3389/fnsys.2014.00228
   PubMedGoogle Scholar
• Singh, I., Bard, I., & Jackson, J. (2014). Robust resilience and substantial interest: A survey of pharmacological cognitive enhancement among university students in the UK and Ireland. PLOS One, 9, 1–12. doi:10.1371/journal.pone.0105969
   Web of Science ®Google Scholar
• Vargo, E., & Petroczi, A. (2016). It was me on a good day: Exploring the smart drug use phenomenon in England. Frontiers in Psychology, 7, 779. doi:10.3389/fpsyg.2016.00779
   PubMed Web of Science ®Google Scholar
• Vrecko, S. (2013). Just how cognitive is cognitive enhancement? on the significance of emotions in university students' experiences with study drugs. AJOB Neuroscience, 4, 4–12. doi:10.1080/21507740.2012.740141
   PubMedGoogle Scholar
• Webster, A., Douglas, C., & Lewis, G. (2009). Making sense of medicines: Lay pharmacology and narratives of safety and efficacy. Science as Culture, 18, 233–247. doi:10.1080/09505430902885631
   Web of Science ®Google Scholar
• White, B., Becker-Blease, K., & Grace-Bishop, K. (2006). Stimulant medication use, misuse and abuse in an undergraduate and graduate student sample. Journal of American College Health, 54, 261–268. doi:10.3200/JACH.54.5.261-268
   PubMed Web of Science ®Google Scholar
• Williams, S., Martin, P., & Gabe, J. (2011). The pharmaceuticalisation of society? A framework for analysis. Sociology of Health and Illness, 33, 710–725.
   PubMed Web of Science ®Google Scholar
• Williams, S., Coveney, C., & Gabe, J. (2013). Medicalisation or customisation? Sleep, enterprise and enhancement in the 24/7 society. Sociology of Health and Illness, 33, 710–725. doi:10.1111/j.1467-9566.2011.01320.x
   Google Scholar